Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
Alkermes/Biogen hope for less tummy trouble with new MS pill
Pharmaforum
Tue, 12/18/18 - 10:28 am
Alkermes
Biogen
MS
multiple sclerosis
Vumerity
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Biogen backs away from AGTC after gene therapy failure
BioPharma Dive
Thu, 12/13/18 - 09:10 pm
gene therapy
Biogen
Applied Genetic Technologies
Biogen bails on AGTC after ocular gene therapy flunks trial
Fierce Biotech
Thu, 12/13/18 - 12:20 pm
Applied Genetic Technologies
gene therapy
Biogen
rAAV2tYF-CB-hRS1
Biogen opts in for Ionis' ALS candidate, plans pivotal trial
BioCentury
Thu, 12/6/18 - 06:56 pm
BIIB067
Biogen
Ionis Pharmaceuticals
ALS
Biogen tasks HitGen with discovering neurological leads
Fierce Biotech
Wed, 11/21/18 - 09:51 am
Biogen
HitGen
drug discovery
DNA
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million
BioSpace
Wed, 11/7/18 - 12:29 pm
Biogen
Samsung Bioepis
biosimilars
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Sun, 10/28/18 - 07:42 pm
Big Pharma
biosimilars
Novartis
Amgen
Merck
Pfizer
Biogen
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
Reuters
Wed, 10/24/18 - 11:46 pm
Biogen
Tecfidera
MS
Forward Pharma
Biogen Rides the Spinraza Wave to Double-Digit Growth
Motley Fool
Wed, 10/24/18 - 11:35 pm
Biogen
earnings
Biogen sees two phase 2 failures: In sciatica and in its lupus collaboration with UCB
Fierce Biogen
Tue, 10/23/18 - 01:40 pm
UCB Pharma
Biogen
dapirolizumab pegol
vixotrigine
lupus
sciatica
UCB, Biogen admit defeat in PhII lupus trial, adding to a string of late-stage failures in the field
Endpoints
Tue, 10/23/18 - 10:37 am
UCB Pharma
Biogen
dapirolizumab pegol
DZP
lupus
clinical trials
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
Researchers behind Biogen’s breakthrough drug win big at ‘Oscars of science’
Stat
Thu, 10/18/18 - 12:14 am
Biogen
Spinraza
Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
Fierce Pharma
Mon, 10/8/18 - 11:37 pm
Biogen
Spinraza
spinal muscular atrophy
SMA
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Parkinson's Patient Files Discrimination Lawsuit Against Biogen, Adding to Other Former Employee Suits
BioSpace
Fri, 10/5/18 - 12:05 pm
Biogen
discrimination
disabilities
Parkinson's Disease
AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more
Fierce Pharma
Tue, 09/25/18 - 07:19 pm
AbbVie
Biogen
Sanofi
Gilead Sciences
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Fri, 08/31/18 - 11:44 pm
Biogen
Teva Pharmaceutical
MS
multiple sclerosis
payers
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »